News

BioTech intends to add more assets and increased revenue for the company in 2008 to bring more value to the stock. BioBody is an eight-year-old Texas company that

This method patent covers the use of multispectral imaging combined with spectral unmixing to greatly increase the signal-to-noise level of fluorophores in a living mammal. The unmixing of

Niacin is a treatment is used to increase high density lipoprotein (HDL) and modestly decrease triglyceride levels in dyslipidemia or cholesterol management. Ultra-pure ethyl EPA prescribed in Japan

In addition to seeking guidance on the P2V diagnostic test, the pre- investigational device exemption (IDE) application will also include an investigational plan overview for the tumor grading

The circulatory system devices advisory panel to the FDA voted to recommend the Xience V stent system for approval with conditions related to post-marketing study requirements and language

Lilly’s $1.6 million contribution will finance programs between 2008 and 2011. In 2008 alone, the International Federation will expand its support to 10 additional MDR-TB programs in Kazakhstan,

This is the first clinical trial of a compound in this collaboration to discover novel therapies targeted against LXR, a nuclear hormone receptor implicated in a variety of

Existing investors Ampersand Ventures, Adams Street Partners and Tang Capital Management participated in the financing. Ronald Berg, president and CEO of RadPharm, said: “This financing marks another key

The procedure was performed as part of NeoVista’s Cabernet trial, which seeks to enroll a total of 450 patients (300 in the radiation treatment arm) in approximately 40